Literature DB >> 29683085

Deconstruction of HLA-DRB1*04:01:01 and HLA-DRB1*15:01:01 class II haplotypes using next-generation sequencing in European-Americans with multiple sclerosis.

Lisa E Creary1, Kalyan C Mallempati2, Sridevi Gangavarapu2, Stacy J Caillier3, Jorge R Oksenberg3, Marcelo A Fernández-Viňa1.   

Abstract

BACKGROUND: The association between HLA-DRB1*15:01 with multiple sclerosis (MS) susceptibility is well established, but the contribution of the tightly associated HLA-DRB5*01:01 allele has not yet been completely ascertained. Similarly, the effects of HLA-DRB1*04:01 alleles and haplotypes, defined at the full-gene resolution level with MS risk remains to be elucidated.
OBJECTIVES: To characterize the molecular architecture of class II HLA-DR15 and HLA-DR4 haplotypes associated with MS.
METHODS: Next-generation sequencing was used to determine HLA-DQB1, HLA-DQA1, and HLA-DRB1/4/5 alleles in 1403 unrelated European-American patients and 1425 healthy unrelated controls. Effect sizes of HLA alleles and haplotypes on MS risk were measured by odds ratio (OR) with 95% confidence intervals.
RESULTS: HLA-DRB1*15:01:01:01SG (OR = 3.20, p < 2.2E-16), HLA-DRB5*01:01:01 (OR = 2.96, p < 2.2E-16), and HLA-DRB5*01:01:01v1_STR1 (OR = 8.18, p = 4.3E-05) alleles all occurred at significantly higher frequencies in MS patients compared to controls. The most significant predis-posing haplotypes were HLA-DQB1*06:02:01~ HLA-DQA1*01:02:01:01SG~HLA-DRB1*15:01:01:01SG~HLA-DRB5*01:01:01 and HLA-DQB1*06:02:01~HLA-DQA1*01:02:01:01SG~HLA-DRB1*15:01:01:01SG~HLA-DRB5*01:01:01v1_STR1 (OR = 3.19, p < 2.2E-16; OR = 9.30, p = 9.7E-05, respectively). Analyses of the HLA-DRB1*04 cohort in the absence of HLA-DRB1*15:01 haplotypes revealed that the HLA-DQB1*03:01:01:01~HLA-DQA1*03:03:01:01~HLA-DRB1*04:01:01:01SG~HLA-DRB4*01:03:01:01 haplotype was protective (OR = 0.64, p = 0.028), whereas the HLA-DQB1*03:02:01~HLA-DQA1*03:01:01~HLA-DRB1*04:01:01:01SG~HLA-DRB4*01:03:01:01 haplotype was associated with MS susceptibility (OR = 1.66, p = 4.9E-03).
CONCLUSION: HLA-DR15 haplotypes, including genomic variants of HLA-DRB5, and HLA-DR4 haplotypes affect MS risk.

Entities:  

Keywords:  European-Americans; Human leukocyte antigen ; haplotype; multiple sclerosis; next-generation sequencing; protection; susceptibility

Mesh:

Substances:

Year:  2018        PMID: 29683085      PMCID: PMC6365219          DOI: 10.1177/1352458518770019

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  34 in total

1.  HLA-DR15 is associated with lower age at onset in multiple sclerosis.

Authors:  T Masterman; A Ligers; T Olsson; M Andersson; O Olerup; J Hillert
Journal:  Ann Neurol       Date:  2000-08       Impact factor: 10.422

2.  Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.

Authors:  David A Dyment; Blanca M Herrera; M Zameel Cader; Cristen J Willer; Matthew R Lincoln; A Dessa Sadovnick; Neil Risch; George C Ebers
Journal:  Hum Mol Genet       Date:  2005-06-01       Impact factor: 6.150

3.  Multiple sclerosis: association with HL-A3.

Authors:  S Naito; N Namerow; M R Mickey; P I Terasaki
Journal:  Tissue Antigens       Date:  1972

4.  Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.

Authors:  Lisa F Barcellos; Stephen Sawcer; Patricia P Ramsay; Sergio E Baranzini; Glenys Thomson; Farren Briggs; Bruce C A Cree; Ann B Begovich; Pablo Villoslada; Xavier Montalban; Antonio Uccelli; Giovanni Savettieri; Robin R Lincoln; Carolyn DeLoa; Jonathan L Haines; Margaret A Pericak-Vance; Alastair Compston; Stephen L Hauser; Jorge R Oksenberg
Journal:  Hum Mol Genet       Date:  2006-08-11       Impact factor: 6.150

5.  A functional and structural basis for TCR cross-reactivity in multiple sclerosis.

Authors:  Heather L E Lang; Helle Jacobsen; Shinji Ikemizu; Christina Andersson; Karl Harlos; Lars Madsen; Peter Hjorth; Leif Sondergaard; Arne Svejgaard; Kai Wucherpfennig; David I Stuart; John I Bell; E Yvonne Jones; Lars Fugger
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

6.  Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis.

Authors:  Jacqueline A Quandt; Jaebong Huh; Mirza Baig; Karen Yao; Naoko Ito; Mark Bryant; Kazuyuki Kawamura; Clemencia Pinilla; Henry F McFarland; Roland Martin; Kouichi Ito
Journal:  J Immunol       Date:  2012-08-10       Impact factor: 5.422

7.  Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases.

Authors:  John D Rioux; Philippe Goyette; Timothy J Vyse; Lennart Hammarström; Michelle M A Fernando; Todd Green; Philip L De Jager; Sylvain Foisy; Joanne Wang; Paul I W de Bakker; Stephen Leslie; Gilean McVean; Leonid Padyukov; Lars Alfredsson; Vito Annese; David A Hafler; Qiang Pan-Hammarström; Ritva Matell; Stephen J Sawcer; Alastair D Compston; Bruce A C Cree; Daniel B Mirel; Mark J Daly; Tim W Behrens; Lars Klareskog; Peter K Gregersen; Jorge R Oksenberg; Stephen L Hauser
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-21       Impact factor: 11.205

8.  Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis.

Authors:  Stacy J Caillier; Farren Briggs; Bruce A C Cree; Sergio E Baranzini; Marcelo Fernandez-Viña; Patricia P Ramsay; Omar Khan; Walter Royal; Stephen L Hauser; Lisa F Barcellos; Jorge R Oksenberg
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

9.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.

Authors:  Stephen Sawcer; Garrett Hellenthal; Matti Pirinen; Chris C A Spencer; Nikolaos A Patsopoulos; Loukas Moutsianas; Alexander Dilthey; Zhan Su; Colin Freeman; Sarah E Hunt; Sarah Edkins; Emma Gray; David R Booth; Simon C Potter; An Goris; Gavin Band; Annette Bang Oturai; Amy Strange; Janna Saarela; Céline Bellenguez; Bertrand Fontaine; Matthew Gillman; Bernhard Hemmer; Rhian Gwilliam; Frauke Zipp; Alagurevathi Jayakumar; Roland Martin; Stephen Leslie; Stanley Hawkins; Eleni Giannoulatou; Sandra D'alfonso; Hannah Blackburn; Filippo Martinelli Boneschi; Jennifer Liddle; Hanne F Harbo; Marc L Perez; Anne Spurkland; Matthew J Waller; Marcin P Mycko; Michelle Ricketts; Manuel Comabella; Naomi Hammond; Ingrid Kockum; Owen T McCann; Maria Ban; Pamela Whittaker; Anu Kemppinen; Paul Weston; Clive Hawkins; Sara Widaa; John Zajicek; Serge Dronov; Neil Robertson; Suzannah J Bumpstead; Lisa F Barcellos; Rathi Ravindrarajah; Roby Abraham; Lars Alfredsson; Kristin Ardlie; Cristin Aubin; Amie Baker; Katharine Baker; Sergio E Baranzini; Laura Bergamaschi; Roberto Bergamaschi; Allan Bernstein; Achim Berthele; Mike Boggild; Jonathan P Bradfield; David Brassat; Simon A Broadley; Dorothea Buck; Helmut Butzkueven; Ruggero Capra; William M Carroll; Paola Cavalla; Elisabeth G Celius; Sabine Cepok; Rosetta Chiavacci; Françoise Clerget-Darpoux; Katleen Clysters; Giancarlo Comi; Mark Cossburn; Isabelle Cournu-Rebeix; Mathew B Cox; Wendy Cozen; Bruce A C Cree; Anne H Cross; Daniele Cusi; Mark J Daly; Emma Davis; Paul I W de Bakker; Marc Debouverie; Marie Beatrice D'hooghe; Katherine Dixon; Rita Dobosi; Bénédicte Dubois; David Ellinghaus; Irina Elovaara; Federica Esposito; Claire Fontenille; Simon Foote; Andre Franke; Daniela Galimberti; Angelo Ghezzi; Joseph Glessner; Refujia Gomez; Olivier Gout; Colin Graham; Struan F A Grant; Franca Rosa Guerini; Hakon Hakonarson; Per Hall; Anders Hamsten; Hans-Peter Hartung; Rob N Heard; Simon Heath; Jeremy Hobart; Muna Hoshi; Carmen Infante-Duarte; Gillian Ingram; Wendy Ingram; Talat Islam; Maja Jagodic; Michael Kabesch; Allan G Kermode; Trevor J Kilpatrick; Cecilia Kim; Norman Klopp; Keijo Koivisto; Malin Larsson; Mark Lathrop; Jeannette S Lechner-Scott; Maurizio A Leone; Virpi Leppä; Ulrika Liljedahl; Izaura Lima Bomfim; Robin R Lincoln; Jenny Link; Jianjun Liu; Aslaug R Lorentzen; Sara Lupoli; Fabio Macciardi; Thomas Mack; Mark Marriott; Vittorio Martinelli; Deborah Mason; Jacob L McCauley; Frank Mentch; Inger-Lise Mero; Tania Mihalova; Xavier Montalban; John Mottershead; Kjell-Morten Myhr; Paola Naldi; William Ollier; Alison Page; Aarno Palotie; Jean Pelletier; Laura Piccio; Trevor Pickersgill; Fredrik Piehl; Susan Pobywajlo; Hong L Quach; Patricia P Ramsay; Mauri Reunanen; Richard Reynolds; John D Rioux; Mariaemma Rodegher; Sabine Roesner; Justin P Rubio; Ina-Maria Rückert; Marco Salvetti; Erika Salvi; Adam Santaniello; Catherine A Schaefer; Stefan Schreiber; Christian Schulze; Rodney J Scott; Finn Sellebjerg; Krzysztof W Selmaj; David Sexton; Ling Shen; Brigid Simms-Acuna; Sheila Skidmore; Patrick M A Sleiman; Cathrine Smestad; Per Soelberg Sørensen; Helle Bach Søndergaard; Jim Stankovich; Richard C Strange; Anna-Maija Sulonen; Emilie Sundqvist; Ann-Christine Syvänen; Francesca Taddeo; Bruce Taylor; Jenefer M Blackwell; Pentti Tienari; Elvira Bramon; Ayman Tourbah; Matthew A Brown; Ewa Tronczynska; Juan P Casas; Niall Tubridy; Aiden Corvin; Jane Vickery; Janusz Jankowski; Pablo Villoslada; Hugh S Markus; Kai Wang; Christopher G Mathew; James Wason; Colin N A Palmer; H-Erich Wichmann; Robert Plomin; Ernest Willoughby; Anna Rautanen; Juliane Winkelmann; Michael Wittig; Richard C Trembath; Jacqueline Yaouanq; Ananth C Viswanathan; Haitao Zhang; Nicholas W Wood; Rebecca Zuvich; Panos Deloukas; Cordelia Langford; Audrey Duncanson; Jorge R Oksenberg; Margaret A Pericak-Vance; Jonathan L Haines; Tomas Olsson; Jan Hillert; Adrian J Ivinson; Philip L De Jager; Leena Peltonen; Graeme J Stewart; David A Hafler; Stephen L Hauser; Gil McVean; Peter Donnelly; Alastair Compston
Journal:  Nature       Date:  2011-08-10       Impact factor: 49.962

10.  Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects.

Authors:  Nikolaos A Patsopoulos; Lisa F Barcellos; Rogier Q Hintzen; Catherine Schaefer; Cornelia M van Duijn; Janelle A Noble; Towfique Raj; Pierre-Antoine Gourraud; Barbara E Stranger; Jorge Oksenberg; Tomas Olsson; Bruce V Taylor; Stephen Sawcer; David A Hafler; Mary Carrington; Philip L De Jager; Paul I W de Bakker
Journal:  PLoS Genet       Date:  2013-11-21       Impact factor: 5.917

View more
  8 in total

Review 1.  Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis.

Authors:  Carol Chase Huizar; Itay Raphael; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2020-09-20       Impact factor: 4.868

2.  Next-generation sequencing reveals new information about HLA allele and haplotype diversity in a large European American population.

Authors:  Lisa E Creary; Sridevi Gangavarapu; Kalyan C Mallempati; Gonzalo Montero-Martín; Stacy J Caillier; Adam Santaniello; Jill A Hollenbach; Jorge R Oksenberg; Marcelo A Fernández-Viña
Journal:  Hum Immunol       Date:  2019-07-22       Impact factor: 2.850

3.  Report from the Killer-cell Immunoglobulin-like Receptors (KIR) component of the 17th International HLA and Immunogenetics Workshop.

Authors:  Maneesh K Misra; Danillo G Augusto; Gonzalo Montero Martin; Neda Nemat-Gorgani; Jürgen Sauter; Jan A Hofmann; James A Traherne; Betsy González-Quezada; Clara Gorodezky; Will P Bultitude; Wesley Marin; Cynthia Vierra-Green; Kirsten M Anderson; Antonio Balas; Jose L Caro-Oleas; Elisa Cisneros; Francesco Colucci; Ravi Dandekar; Sally M Elfishawi; Marcelo A Fernández-Viña; Merhan Fouda; Rafael González-Fernández; Arend Große; Maria J Herrero-Mata; Sam Q Hollenbach; Steven G E Marsh; Alex Mentzer; Derek Middleton; Ashley Moffett; Miguel A Moreno-Hidalgo; Ghada I Mossallam; Annettee Nakimuli; Jorge R Oksenberg; Stephen J Oppenheimer; Peter Parham; Maria-Luiza Petzl-Erler; Dolores Planelles; Florentino Sánchez-García; Francisco Sánchez-Gordo; Alexander H Schmidt; John Trowsdale; Luciana B Vargas; Jose L Vicario; Carlos Vilches; Paul J Norman; Jill A Hollenbach
Journal:  Hum Immunol       Date:  2018-10-12       Impact factor: 2.850

4.  High-resolution HLA allele and haplotype frequencies in several unrelated populations determined by next generation sequencing: 17th International HLA and Immunogenetics Workshop joint report.

Authors:  Lisa E Creary; Nicoletta Sacchi; Michela Mazzocco; Gerald P Morris; Gonzalo Montero-Martin; Winnie Chong; Colin J Brown; Amalia Dinou; Catherine Stavropoulos-Giokas; Clara Gorodezky; Saranya Narayan; Srinivasan Periathiruvadi; Rasmi Thomas; Dianne De Santis; Jennifer Pepperall; Gehad E ElGhazali; Zain Al Yafei; Medhat Askar; Shweta Tyagi; Uma Kanga; Susana R Marino; Dolores Planelles; Chia-Jung Chang; Marcelo A Fernández-Viña
Journal:  Hum Immunol       Date:  2021-05-24       Impact factor: 2.211

5.  HLA Class II Genotype Does Not Affect the Myelin Responsiveness of Multiple Sclerosis Patients.

Authors:  Judith Derdelinckx; Irene Nkansah; Naomi Ooms; Laura Van Bruggen; Marie-Paule Emonds; Liesbeth Daniëls; Tatjana Reynders; Barbara Willekens; Patrick Cras; Zwi N Berneman; Nathalie Cools
Journal:  Cells       Date:  2020-12-17       Impact factor: 6.600

6.  Genetic Analyses of Common Infections in the Avon Longitudinal Study of Parents and Children Cohort.

Authors:  Amanda H W Chong; Ruth E Mitchell; Gibran Hemani; George Davey Smith; Robert H Yolken; Rebecca C Richmond; Lavinia Paternoster
Journal:  Front Immunol       Date:  2021-11-04       Impact factor: 7.561

7.  Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations.

Authors:  Lisa E Creary; Sridevi Gangavarapu; Stacy J Caillier; Paola Cavalcante; Rita Frangiamore; Benedicte A Lie; Mats Bengtsson; Hanne Flinstad Harbo; Susanna Brauner; Jill A Hollenbach; Jorge R Oksenberg; Pia Bernasconi; Angelina Hatlø Maniaol; Lennart Hammarström; Renato Mantegazza; Marcelo A Fernández-Viña
Journal:  Front Immunol       Date:  2021-06-07       Impact factor: 7.561

8.  High Resolution Haplotype Analyses of Classical HLA Genes in Families With Multiple Sclerosis Highlights the Role of HLA-DP Alleles in Disease Susceptibility.

Authors:  Kazutoyo Osoegawa; Lisa E Creary; Gonzalo Montero-Martín; Kalyan C Mallempati; Sridevi Gangavarapu; Stacy J Caillier; Adam Santaniello; Noriko Isobe; Jill A Hollenbach; Stephen L Hauser; Jorge R Oksenberg; Marcelo A Fernández-Viňa
Journal:  Front Immunol       Date:  2021-05-25       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.